MedTrace Logo

Demineralized Bone Allograft Fibers Versus Particulate In Sinus Augmentation

NCT06173791 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2026-02-20

No results posted yet for this study

Summary

The purpose of this clinical trial is to assess if the addition of DFDBA fibers to DBBM results in greater vital bone formation than the addition of DFDBA particles to DBBM.

The study team will examine the effects of the addition of DFDBA fibers to DBBM on vital bone formation. Specifically, we will assess histologically the percent vital bone formation with each of the groups during implant placement, six months after the sinus augmentation procedure. We will also evaluate the radiographic volume achieved with both groups of materials.

Conditions

  • Bone Loss in Jaw

Interventions

DEVICE

DFDBA fibers

Bone Allograft fibers used in dental sinus reconstruction surgery

DEVICE

DFDBA particles

Bone Allograft particles used in dental sinus reconstruction surgery

DEVICE

DBBM

DBBM is routinely used in sinus augmentation to support dental implant placement and restoration of missing teeth.

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Angela Palaiologou-Gallis, DDS, MS · The University of Texas Health Science Center at San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-25
Primary Completion
2026-02-10
Completion
2026-02-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06173791 on ClinicalTrials.gov